$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon Therapeutics (NASDAQ:HZNP) Upgraded to "Strong-Buy" by BidaskClub
07:38am, Wednesday, 22'nd Apr 2020
Horizon Therapeutics (NASDAQ:HZNP) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Wednesday, BidAskClub reports. Ot
Horizon Therapeutics Plc (HZNP) EVP, Chief Human Resources Off Irina Konstantinovsky Sold ...
12:00am, Tuesday, 21'st Apr 2020Brian K. Beeler Sells 9,000 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP) Stock
08:58am, Sunday, 19'th Apr 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) EVP Brian K. Beeler sold 9,000 shares of Horizon Therapeutics stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $32.51
Piper Sandler Comments on Horizon Therapeutics PLC's FY2020 Earnings (NASDAQ:HZNP)
07:14am, Friday, 17'th Apr 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) – Piper Sandler decreased their FY2020 earnings per share (EPS) estimates for Horizon Therapeutics in a research note issued to investors on Monday, April 13th
Rhenman & Partners Asset Management AB Buys AbbVie Inc, Zimmer Biomet Holdings Inc, CVS ...
12:00am, Thursday, 16'th Apr 2020Can Horizon Therapeutics (HZNP) Keep the Earnings Surprise Streak Alive?
04:10pm, Wednesday, 15'th Apr 2020
Horizon Therapeutics (HZNP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Horizon Therapeutics plc to Release First-Quarter 2020 Financial Results and Host Webcast on May 6, 2020
12:00pm, Wednesday, 15'th Apr 2020
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its first-quarter 2020 financial results will be released on Wednesday, May 6, 2020. Following the announcement, Horizon's management will
Should You Buy These 4 Biotech Stocks With Recent Drug Approvals?
10:45am, Wednesday, 15'th Apr 2020
These companies scored recent drug approvals. It's worth looking into their stocks to see if they're a buy now.
Piper Sandler Comments on Horizon Therapeutics PLC's Q1 2020 Earnings (NASDAQ:HZNP)
10:42am, Wednesday, 15'th Apr 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) – Equities researchers at Piper Sandler increased their Q1 2020 earnings per share estimates for shares of Horizon Therapeutics in a report released on Monday,
Can Horizon Therapeutics (HZNP) Keep the Earnings Surprise Streak Alive?
12:00am, Wednesday, 15'th Apr 2020
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on Horizon Therapeutics (
HZNP
–
Research Report
) and Madrigal Pharmaceuticals (
MDGL
–
Research Repo
Macquarie Group Ltd. Purchases Shares of 9,300 Horizon Therapeutics PLC (NASDAQ:HZNP)
11:26am, Tuesday, 14'th Apr 2020
Macquarie Group Ltd. purchased a new stake in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The instituti
Horizon Therapeutics (NASDAQ:HZNP) Downgraded to Buy at BidaskClub
10:20am, Tuesday, 14'th Apr 2020
Horizon Therapeutics (NASDAQ:HZNP) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Tuesday, BidAskClub re
Piper Sandler Maintains Overweight on Horizon Therapeutics, Lowers Price Target to $44
12:00am, Tuesday, 14'th Apr 2020Cubist Systematic Strategies LLC Sells 79,280 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP)
08:54am, Sunday, 12'th Apr 2020
Cubist Systematic Strategies LLC lowered its position in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 87.0% during the fourth quarter, according to the company in its most recent disclosure wit
Sign In
Buy HZNP